期刊文献+

野百合碱诱导的肺动脉高压大鼠TGF-β1/Smad2信号通路表达的研究 被引量:3

The expression of TGF-β1 /Smad2 signaling pathway in monocrotaline-induced pulmonary hypertension in rats
下载PDF
导出
摘要 目的:研究TGF-β1/Smad2信号通路在野百合碱诱导的肺动脉高压大鼠中的表达。方法:18只雄性SD大鼠随机分为对照组和模型组,采用皮下注射野百合碱(60 mg/kg)的方法复制肺动脉高压模型。野百合碱注射5w后,测定大鼠右心室收缩压(RVSP)和右心室肥厚指数(RVHI)。Western blot检测肺组织中TGF-β1、p-Smad2和Smad2的表达水平。结果:模型组大鼠的RVSP、RVHI明显高于对照组,模型组大鼠肺组织中TGF-β1、p-Smad2的表达明显高于对照组。结论:TGF-β1/Smad2信号通路可能参与了肺动脉高压发病过程。 Objective:To explore the expression of TGF-IM/Smad2 signaling pathway in monocrotaline induced pulmonary hypertension in rats. Methods: 18 male Sprague-Dawley rats were randomly divided into control group and model group. The rats in the model group were underwent a subcutaneous injection of 60 mg/ kg monocrotaline(MCT). Five weeks after injection, fight ventricular systolic pressure (RVSP) and right ventficular hypertrophy index (RVHI) were measured. The expression levels of TGF-β1, p-Smad2 and Smad2 in the lung tissue were detected by Western blot. Results: RVSP and RVHI in the model group were significantly higher than that in the control group. The expression of TGF-β1 and p-Smad2 in the lung was also significantly higher than that in the control group. Conclusion: TGF-β1/Smad2 signaling pathway may be involved in the pathogenesis of pulmonary hypertension.
出处 《心肺血管病杂志》 CAS 2014年第3期442-444,共3页 Journal of Cardiovascular and Pulmonary Diseases
基金 国家自然科学基金资助项目(编号:30971274)
关键词 肺动脉高压 野百合碱 TGF-Β1 SMAD2 Pulmonary hypertension Monocrotaline Transforming growth factor-β1 Smad2
  • 相关文献

参考文献8

  • 1Marc H, Olivier S. Treatment of Pulmonary Artery Hypertension. N Engl J Med, 2004, 351: 1425-1436.
  • 2Eickelberg O, Morty RE. Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited. Trends Cardiovasc Med, 2007, 17 : 263- 269.
  • 3张颖,刘双,杨京华.肺动脉高压诊断及分类[J].心肺血管病杂志,2008,27(3):191-192. 被引量:15
  • 4Wilson DW, Segall H J, Pan LC, et al. Mechanisms and patholo- gy of monocrotaline pulmonary toxicity. Crit Rev Toxicol, 1992, 22 : 307-325.
  • 5Alex B. Transforming growth factors and vascular disorders. Ar- terioscler Thromb Vase Biol, 2006, 26 : 1712-1720.
  • 6Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003, 425: 577-584.
  • 7Lambers C, Roth M, Zhong J, et al. The interaction of endothe- lin-1 and TGF-[51 mediates vascular cell remodeling. PLoS One, 2013, 28, 8: e73399.
  • 8Megalou A J, Glava C, Oikonomidis DL, et al. Transforming growth factor-13 inhibition attenuates pulmonary arterial hyperten- sion in rats. Int J Clin Exp Med,2010, 3: 332-340.

二级参考文献10

  • 1荆志成,徐希奇.肺动脉高压现代分类和诊断策略[J].中华心血管病杂志,2004,32(12):1160-1162. 被引量:40
  • 2王秋芬,廖玉华.欧洲心脏病协会2004年肺动脉高压诊断和治疗指南简介[J].临床心血管病杂志,2005,21(7):385-386. 被引量:57
  • 3程显声,郭英华,何建国,荆志成.1996—2005年阜外心血管病医院肺动脉高压住院构成比变化[J].中华心血管病杂志,2007,35(3):251-254. 被引量:34
  • 4荆志诚,主译.肺动脉高压康复指南.3版.北京:人民军医出版社,2006:38-39.
  • 5Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol, 2004,43 ( suppl 12) : S 13 - S24.
  • 6Christman BW, McPherson CD, Newman J H, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med, 1992,327 : 70-75.
  • 7Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med, 1999,159 : 1925-1932.
  • 8McQuillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic p ressure among echocardiographically normal subjects. Circulation, 2001, 104:2797 - 2802.
  • 9Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolisml. N Engl J Med, 2004, 350: 2257- 2264.
  • 10曹铁生,袁丽君,段云友,S.M.沙皮洛,B.H.布朗得基.超声心动图法测定肺动脉收缩压的可靠性和存在问题[J].第四军医大学学报,2000,21(11):1387-1389. 被引量:16

共引文献14

同被引文献25

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部